Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,461,419 | 1,517,855 | N/A | -17,273 | -29,192 |
| Depreciation Amortization | 36,714 | 46,394 | N/A | 5 | 24 |
| Accounts receivable | 159,861 | 111,529 | N/A | N/A | N/A |
| Other Working Capital | 260,584 | 490,213 | N/A | -241 | 97 |
| Other Operating Activity | -1,251,339 | -547,674 | 0 | 1,928 | 3,742 |
| Operating Cash Flow | $1,667,239 | $1,618,317 | $N/A | $-15,581 | $-25,329 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,721,291 | -269,593 | N/A | N/A | N/A |
| Purchase Of Investment | -1,307,404 | -176,983 | N/A | N/A | N/A |
| Sale Of Investment | 875,070 | 750,000 | N/A | N/A | N/A |
| Investing Cash Flow | $-2,153,625 | $303,424 | $N/A | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -294,000 | -294,000 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 2,876 | 102 |
| Common Stock Repurchased | -4,266 | N/A | N/A | N/A | N/A |
| Dividend Paid | -893,360 | -1,083,052 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -2,049 | 0 | 0 | 0 |
| Financing Cash Flow | $-1,191,626 | $-1,379,101 | $N/A | $2,876 | $102 |
| Beginning Cash Position | 1,924,211 | 1,381,571 | N/A | 21,393 | 46,620 |
| End Cash Position | 246,199 | 1,924,211 | N/A | 8,688 | 21,393 |
| Net Cash Flow | $-1,678,012 | $542,640 | $N/A | $-12,705 | $-25,227 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,667,239 | 1,618,317 | N/A | -15,581 | -25,329 |
| Capital Expenditure | -1,721,291 | -269,593 | N/A | 0 | 0 |
| Free Cash Flow | -54,052 | 1,348,724 | 0 | -15,581 | -25,329 |